Q3 2023 · 13F-HR
Artia Global Partners LPholdings as filed
Filed 2023-11-14 · accession 0001937964-23-000006
$240.6M
Reported value
27
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670100205 | NVO | NOVO-NORDISK A S | $62.0M | 25.8% | 681,812 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $33.9M | 14.1% | 329,200 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $24.2M | 10.1% | 49,238 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $14.1M | 5.85% | 26,193 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $13.5M | 5.63% | 90,821 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $12.9M | 5.37% | 190,752 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $10.9M | 4.51% | 51,175 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $10.7M | 4.44% | 914,023 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $7.2M | 2.99% | 465,465 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $6.9M | 2.89% | 78,465 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $6.9M | 2.88% | 57,162 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $6.4M | 2.65% | 18,314 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $6.1M | 2.55% | 87,848 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $5.1M | 2.10% | 45,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $4.2M | 1.77% | 383,580 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $2.8M | 1.18% | 15,971 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $2.2M | 0.90% | 41,600 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $2.0M | 0.82% | 38,555 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $1.9M | 0.78% | 112,340 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.7M | 0.72% | 100,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $1.4M | 0.56% | 6,905 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $1.1M | 0.44% | 2,109 | Common | SOLE |
| 941848103 | WAT | WATERS CORP | $780,127 | 0.32% | 2,845 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $623,134 | 0.26% | 45,253 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $615,202 | 0.26% | 41,261 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $350,220 | 0.15% | 25,452 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $163,692 | 0.07% | 95,170 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.